Compassionate Use of Omegaven® for the Treatment of Intestinal Failure Associated Liver Disease in Children
Compassionate Use of an Intravenous Fish Oil Lipid Emulsion (Omegaven®) for the Treatment of Intestinal Failure Associated Liver Disease in Children
Sponsor: Children's Hospital and Medical Center, Omaha, Nebraska
This observational or N/A phase trial investigates Total Parenteral Nutrition-Induced Cholestasis and is currently ongoing. Children's Hospital and Medical Center, Omaha, Nebraska leads this study, which shows 10 recorded versions since 2026 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Approved For Marketing
-
Jul 2024 — Sep 2024 [monthly]
Approved For Marketing
-
Feb 2024 — Jul 2024 [monthly]
Approved For Marketing
Status: Completed → Approved For Marketing · Phase: PHASE2 → None
-
Jan 2021 — Feb 2024 [monthly]
Completed PHASE2
-
Nov 2018 — Jan 2021 [monthly]
Completed PHASE2
Status: Enrolling By Invitation → Completed
▶ Show 5 earlier versions
-
Oct 2018 — Nov 2018 [monthly]
Enrolling By Invitation PHASE2
-
Jun 2018 — Oct 2018 [monthly]
Enrolling By Invitation PHASE2
-
Oct 2017 — Jun 2018 [monthly]
Enrolling By Invitation PHASE2
-
Feb 2017 — Oct 2017 [monthly]
Enrolling By Invitation PHASE2
-
Jan 2017 — Feb 2017 [monthly]
Enrolling By Invitation PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Children's Hospital and Medical Center, Omaha, Nebraska
- University of Nebraska
For direct contact, visit the study record on ClinicalTrials.gov .